vendredi 2 juin 2017

Onco Actu du 2 juin 2017

1. Biologie

Science Snaps: a fly on the wall of cancer research [Cancer Research UK]

3. Prévention

Breastfeeding linked to lower endometrial cancer risk [Reuters]

3.3 Prévention - Vaccins

HIV Status May Affect the Progression of Human Papillomavirus Infection to Cervical Precancer [AACR]

4. Dépistage, diagnostic et pronostic

AACR Publishes First Set of Screening Recommendations Emerging from Childhood Cancer Predisposition Workshop [AACR]

Catching Childhood Cancers Early: Insights Into the AACR Childhood Cancer Predisposition Workshop [AACR]

4.2 Dép., diag. & prono. - Génome

First Analysis of AACR Project GENIE Data Published [AACR]

More than 18,000 Genomic Records from Cancer Patients Available [The Scientist]

No Shortcuts on the Long Road to Evidence-Based Genomic Medicine [JAMA]

5. Traitements

Second paediatric strategy forum on medicine development for mature B cell malignancies in children [EMA]

Report: Paediatric strategy forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies [EMA]

5.12.3 Immunothérapies-combinaisons

Checkpoint combos for cancer are all the rage as trial sponsors line up hundreds of new studies — report [EndPoints]

5.12.5 Immunothérapies - Pharma

More than 240 immuno-oncology treatments in development to fight cancer [PhRMA]

Vaxon announces results of its Phase IIb lung cancer trial of Vx-001, a therapeutic vaccine based on optimized cryptic peptides [Vaxon]

5.2 Pharma

Novartis sees gaps in cancer pipeline but is adamant it doesn’t need an I-O deal [FierceBiotech]

5.2.1 Pharma - Partenariats

Array Lands $31M in Licensing Deal with Japan’s Ono Pharma [Xconomy]

5.3.4 Traitements - AMM (FDA, EMA)

Midostaurin Approved by FDA for Acute Myeloid Leukemia [NCI]

5.4 Traitements - Economie

Cancer costs are up—but there's more to the story than rising prices, report says [FiercePharma]

New report heralds a revolution in cancer R&D trends – and the sticker shock that comes with it [EndPoints]

5.5 ASCO

ASCO 2017: Oncology Leaders Pick Their Top Abstracts [OncLive] ASCO (général) - Académiques

More than 10 Roswell Park Teams to Present New Research Findings at ASCO 2017 Annual Meeting [Roswell Park Cancer Institute]

Tip Sheet: Immunotherapy Trial Results for Cancer among Research Presentations by Johns Hopkins Scientists [Johns Hopkins]

Fred Hutch scientists to discuss new treatments, public health findings and more at ASCO meeting [Fred Hutch]

ASCO Annual Meeting 2017 to highlight advances in patient and survivor care [Institute of Cancer Research]

5.5.16 ASCO (médecine de précision)

Researchers Discuss Regulatory Considerations for Tissue-Agnostic Cancer Drugs [RAPS]

5.5.2 ASCO (sein)

Novartis presents updated data that reinforce the efficacy and safety of Kisqali® (ribociclib) plus letrozole as a first-line option for HR+/HER2- advanced or metastatic breast cancer [Novartis]

5.5.4 ASCO (immunothérapies)

Immune responses from early study of novel sarcoma vaccine [Fred Hutch]

6.11 Patients

Saying goodbye to my cancer patients is the best part of my job [The Guardian]

6.6 Publications

Peer review is a thankless job. One firm wants to change that [The Economist]

Web of Science owner buys up booming peer-review platform [Nature]

6.7 DMP, Big Data & applis

Philips and Memorial Sloan Kettering Cancer Center announce research agreement to jointly develop advanced genome analytics for precision oncology [Philips]

Flatiron Health Announces Strategic Collaboration with the National Cancer Institute to Explore Use of Real-World Evidence in Clinical Trial Design [Flatiron]

CancerLinQ and National Cancer Institute Announce Partnership to Enhance Patient Care and Strengthen Cancer Surveillance [ASCO]

CancerLinQ Partners with FDA to Study Real-World Use of Newly Approved Cancer Treatments [ASCO]